We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. The role of IGF/IGF-1R signaling in the regulation of cancer stem cells

    Cancer stem cells (CSCs) are a group of tumor cells with high tumorigenic ability and self-renewal potential similar to those of normal stem...

    Fengchao Liu, Susu Ye, ... Qinghui Niu in Clinical and Translational Oncology
    Article 12 June 2024
  2. IGF-1’s protective effect on OSAS rats’ learning and memory

    Purpose

    Patients with obstructive sleep apnea syndrome (OSAS) frequently experience cognitive dysfunction, which may be connected to chronic...

    Ling Zeng, Ting Yu, ... ** Xu in Sleep and Breathing
    Article Open access 11 June 2024
  3. An exploratory study of clinical factors associated with IGF-1 and IGFBP-3 in preterm infants

    Background

    Despite advances in parenteral nutrition, postnatal growth failure in very low birthweight (VLBW) preterm infants is common and associated...

    Megan E. Paulsen, Nicholas Marka, ... Sara E. Ramel in Pediatric Research
    Article 08 January 2024
  4. Muscle hypertrophy training does not suppress the GH/IGF axis in young adult males

    Purpose

    This study aimed to analyze the expression of the IGF type-1 receptor gene (IGF-1r) and IGF-I, GH, testosterone, and IGFBP-3 concentrations in...

    M. C. Junior, H. S. C. Cerqueira, ... C. E. M. Junior in Journal of Endocrinological Investigation
    Article 24 June 2023
  5. IGF-1 is positively associated with BMI in patients with acromegaly

    Purpose

    Acromegaly is a disorder characterized by IGF-1 excess due to autonomous GH secretion. In individuals without acromegaly, IGF-1 is not only...

    Anamil Khiyami, Neha Mehrotra, ... Pouneh K. Fazeli in Pituitary
    Article 17 March 2023
  6. Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer

    Background

    Growth hormone (GH) resistance is characterized by high GH levels but low levels of insulin-like growth factor-I (IGF-I) and growth hormone...

    Ann-Kathrin Fröhlich, Jan Porthun, ... Markus S. Anker in Clinical Research in Cardiology
    Article Open access 08 April 2024
  7. Very low serum IGF-1 levels are associated with vertebral fractures in adult males with beta-thalassemia major

    Purpose

    Patients with beta-thalassemia major (BTM) often develop several endocrine disorders due to chronic iron overload. They are also prone to...

    G. Costanzo, A. Naselli, ... F. Frasca in Journal of Endocrinological Investigation
    Article 25 March 2024
  8. Recombinant IGF-1/BP3 protects against intestinal injury in a neonatal mouse NEC model

    Background

    Recombinant human IGF-1/binding protein-3 (rhIGF-1/BP3) is currently being tested in phase II clinical trials in premature infants to...

    **aocai Yan, Elizabeth Managlia, ... Isabelle G. De Plaen in Pediatric Research
    Article 28 February 2024
  9. Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight

    Purpose

    An increase of IGF-1 has been reported during therapy with dopamine agonists (DA) for prolactinomas; in such cases a correct diagnosis is...

    S. Caprio, T. Pilli, ... M. G. Castagna in BMC Endocrine Disorders
    Article Open access 20 June 2024
  10. Expression of Salivary and Serum IGF-1 and IGFBP-3 in Individuals With Diabetes and Oral Cancer

    Aim

    To evaluate the expression of salivary and serum Insulin-like growth factor-1 (IGF-1) and Insulin-like growth factor binding protein-3 (IGFBP-3)...

    Rajendra Prabhu Abhinav, Catherine M. Bennett, ... Joanne Williams in Journal of Maxillofacial and Oral Surgery
    Article 24 May 2024
  11. Association between metabolic syndrome, insulin resistance, and IGF-1 in breast cancer survivors of DIANA-5 study

    Purpose

    Circulating insulin-like growth factor-1 (IGF-1) is positively associated with the risk of BC recurrence, and is more frequently dysregulated...

    Mauro De Santi, Giosuè Annibalini, ... Anna Villarini in Journal of Cancer Research and Clinical Oncology
    Article Open access 27 April 2023
  12. A novel role of IGFBP5 in the migration, invasion and spheroids formation induced by IGF-I and insulin in MCF-7 breast cancer cells

    Purpose

    The insulin-like growth factor (IGF) system includes IGF-I, IGF-II insulin and their membrane receptors. IGF system also includes a family of...

    Karem Rodríguez-Rojas, Pedro Cortes-Reynosa, ... Eduardo Perez Salazar in Breast Cancer Research and Treatment
    Article Open access 19 June 2024
  13. Inflammation induces stunting by lowering bone mass via GH/IGF-1 inhibition in very preterm infants

    Background

    Sustained systemic inflammatory response (SIR) was associated with poor postnatal growth in very preterm infants (VPI). We hypothesize that...

    Eduardo Cuestas, Macarena Hillman, ... Alina Rizzotti in Pediatric Research
    Article 20 March 2023
  14. The relationship between morning blood pressure surge and serum IGF-1 level in acromegaly patients with hypertension

    Objective

    High levels of insulin-like growth factor 1 (IGF-1) in patients with acromegaly cause structural and functional changes specific to the...

    Fatih Necip Arici, Erdinc Gulumsek, ... Hilmi Erdem Sumbul in Irish Journal of Medical Science (1971 -)
    Article 27 July 2023
  15. Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis

    Preventing or effectively treating metastatic uveal melanoma (UM) is critical because it occurs in about half of patients and confers a very poor...

    Jackson R. Richards, Donghan Shin, ... Jae Hyuk Yoo in Oncogene
    Article 27 July 2023
  16. The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency

    Purpose

    It is unclear whether the age-related decline in the somatotropic axis stems from a reduced growth hormone (GH) production in the pituitary...

    Olivia Tausendfreund, Martin Bidlingmaier, ... Michael Drey in Pituitary
    Article Open access 31 May 2024
  17. Noncoding RNA actions through IGFs and IGF binding proteins in cancer

    The insulin-like growth factors (IGFs) and their regulatory proteins—IGF receptors and binding proteins—are strongly implicated in cancer progression...

    Aidan Kerr, Robert C. Baxter in Oncogene
    Article Open access 21 May 2022
  18. Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson’s disease patients

    Background

    Insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF) exert neuroprotective effects in Parkinson’s disease (PD). To date,...

    **aoxue Shi, **hua Zheng, ... Mingjian Li in Neurological Sciences
    Article Open access 16 November 2022
  19. Inhibition of the epigenetically activated miR-483-5p/IGF-2 pathway results in rapid loss of meningioma tumor cell viability

    Purpose

    Meningioma is the most common primary central nervous system tumor often causing serious complications, and presently no medical treatment is...

    Erik J. Uhlmann, Charles E. Mackel, ... Anna M. Krichevsky in Journal of Neuro-Oncology
    Article Open access 21 February 2023
  20. Mouse model of Graves’ orbitopathy induced by the immunization with TSHR A and IGF-1R α subunit gene

    Purpose

    The study aimed to establish a mouse model of Graves’ disease (GD) with Graves’ orbitopathy (GO; GD + GO) that can represent the clinical...

    R. Wu, N. Li, ... W. Zheng in Journal of Endocrinological Investigation
    Article 25 April 2024
Did you find what you were looking for? Share feedback.